Department of Pharmaceutical, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Department of Nephrology, Affiliated Hospital of Shanxi University of Chinese Medicine, Taiyuan, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2407206. doi: 10.1080/21645515.2024.2407206. Epub 2024 Sep 25.
Using bibliometric analysis, this study attempted to provide an overview of the current state of research and key findings regarding the immunotherapy for vasculitis in general. We gathered the literature from the Web of Science (WOS) database covering the last 20 years (2004-2024) pertaining to the immunotherapy for vasculitis, and we used Citespace to evaluate the mapping of knowledge. The findings demonstrated that there were 572 articles concerning the immunotherapy for vasculitis, with a faster growth after 2018. The USA, Assistance Publique Hopitaux Paris, and Cornelia M are the nation, organization, and writer with the highest number of publications. Daxini A (2018) is the most frequently mentioned reference as well (26). Prominent universities and developed nations form the finest alliances for research on immunotherapy for vasculitis researches. Immune checkpoint inhibitors, Wegener's granulomatosis, and systemic lupus erythematosus are Three research hotspots in this field.
本研究运用文献计量分析方法，旨在概述血管炎免疫治疗的研究现状和主要发现。我们从 Web of Science（WOS）数据库中收集了过去 20 年（2004-2024 年）有关血管炎免疫治疗的文献，并使用 Citespace 评估知识图谱。结果表明，有 572 篇关于血管炎免疫治疗的文章，2018 年后增长较快。在发表文献数量方面，美国、巴黎公立医院集团和 Cornelia M. 位列国家、机构和作者的前三位。Daxini A（2018）也被高频引述（26 次）。在血管炎免疫治疗领域，知名高校和发达国家之间形成了最紧密的合作关系。免疫检查点抑制剂、韦格纳肉芽肿和系统性红斑狼疮是该领域的三个研究热点。
